Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 antibody test, SARS-CoV-2 test
Clinical narrative: When the patient also sits down he gets a shortness of breath.; patient notices that when he sits down he gets a dry cough.; Chills; Headache; Greater than 35 days between doses of Moderna Covid-19 vaccine.; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA AT REST (When the patient also sits down he gets a shortness of breath.) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K00A and 028M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Patient had covid-19 in month of july and hospitalized for 20 days) in July 2020. Previously administered products included for Product used for unknown indication: Dexamethasone, Monoclonal antibodies and Remdesivir. Past adverse reactions to the above products included No adverse event with Dexamethasone, Monoclonal antibodies and Remdesivir.   On 20-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced DYSPNOEA AT REST (When the patient also sits down he gets a shortness of breath.) (seriousness criterion medically significant), COUGH (patient notices that when he sits down he gets a dry cough.), CHILLS (Chills), HEADACHE (Headache) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Greater than 35 days between doses of Moderna Covid-19 vaccine.). On 19-Feb-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Greater than 35 days between doses of Moderna Covid-19 vaccine.) had resolved. At the time of the report, DYSPNOEA AT REST (When the patient also sits down he gets a shortness of breath.), COUGH (patient notices that when he sits down he gets a dry cough.), CHILLS (Chills) and HEADACHE (Headache) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In July 2020, SARS-CoV-2 test: positive (Positive) Positive. In October 2021, SARS-CoV-2 antibody test: 2500 antibodies. (Inconclusive) 2500 antibodies..         Patient had covid in month of July 2020 and he was hospitalized for 20 days. Treatment medicine includes Plasma No concomitant information reported by the reporter Company comment: This spontaneous case concerns 78 years old male patient with past medical history of COVID-19, and Inappropriate Schedule of product administration who experienced the unexpected serious event of Dyspnoea at rest(Medically significant) and unexpected non serious events of Cough,which occurred on same day  after the second  dose of mRNA 1273 vaccine .The outcome was reported not recovered for Dyspnoe, Cough, Chills and Headache . The benefit-risk relationship of mRNA-1273 in not affected by this report   This case was linked to MOD-2021-436054, MOD-2021-436185, MOD-2021-436121 (Patient Link).; Sender's Comments: This spontaneous case concerns 78 years old male patient with past medical history of COVID-19, and Inappropriate Schedule of product administration who experienced the unexpected serious event of Dyspnoea at rest(Medically significant) and unexpected non serious events of Cough,which occurred on same day  after the second  dose of mRNA 1273 vaccine .The outcome was reported not recovered for Dyspnoe, Cough, Chills and Headache . The benefit-risk relationship of mRNA-1273 in not affected by this report